FULGENT GENETICS INC (FLGT) Stock Analyst Ratings
NASDAQ:FLGT - Nasdaq - US3596641098 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to FLGT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.4. This target is 8.4% above the current price.
FLGT was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about FLGT.
In the previous month the buy percentage consensus was at a similar level.
FLGT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-05-05 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-03-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-03-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-12-07 | UBS | Initiate | Neutral |
| 2023-10-16 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-03-02 | Credit Suisse | Maintains | Outperform |
| 2022-12-08 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-11-18 | Raymond James | Initiate | Outperform |
| 2022-11-14 | Credit Suisse | Maintains | Outperform |
| 2022-11-14 | Piper Sandler | Maintains | Overweight |
| 2022-08-25 | Credit Suisse | Initiate | Outperform |
| 2022-05-16 | Piper Sandler | Maintains | Overweight |
| 2022-01-25 | Oppenheimer | Maintains | Outperform |
| 2021-08-10 | Credit Suisse | Maintains | Underperform |
| 2021-03-05 | Piper Sandler | Maintains | Overweight |